HFA Premium Access

Biomarkers of fibrosis, inflammation, renal dysfunction and its correlations in patients with HFpEF and HFmrEF

Presentation

About the speaker

Doctor Elena Medvedeva

Almazov National Medical Research Centre, Saint-Petersburg (Russian Federation)
0 follower

24 more presentations in this session

The value of NT-proBNP in the diagnosis of cardiac disease in patients with alcoholic liver cirrhosis

Speaker: Associate Professor P. Lazarev (Moscow, RU)

Thumbnail

Not changes in heart failure therapy but patient characteristics at admission predict unsuccessful guidance of therapy to a target of more than 30% NT-proBNP reduction

Speaker: Miss S. Stienen (Amsterdam, NL)

Thumbnail

Sacubitril/valsartan prevents the acute increase of n-terminal brain natriuretic peptide induced by exercise training in subjects with heart failure

Thumbnail

The diagnostic and economic implications of using a plasma nt-probnp of 300 or 400ng/litre as the threshold for ruling out the diagnosis of heart failure in a non selected british population

Speaker: Doctor J. Webb (London, GB)

Thumbnail

Natriuretic peptides for detection of heart failure in patients with atrial fibrillation from the community

Speaker: Professor F. Rutten (Utrecht, NL)

Thumbnail

Access the full session

Poster Session 2 - Biomarkers

Speakers: Doctor E. Medvedeva, Associate Professor P. Lazarev, Miss S. Stienen, Doctor J. Webb, Professor F. Rutten
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk